| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Radnet, Inc. (RDNT) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RDNT is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.20M | $64.32M | - | |
| COO | 530.9K | $28.53M | - | |
| CEO | 498.4K | $26.78M | - | |
| COO | 239.2K | $12.85M | - | |
| VP | 179.5K | $9.65M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 4, 2017 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $10.00 | $50,010.00 | -1.2% | |
| Dec 1, 2017 | Crues John V | Medical Director | Sell | 20,000 | $10.08 | $201,530.00 | -3.4% | |
| Nov 30, 2017 | Hames Norman R56 | Executive Vice President | Sell | 900 | $10.50 | $9,450.00 | -0.2% | |
| Nov 27, 2017 | Crues John V | Medical Director | Sell | 20,000 | $9.89 | $197,758.00 | -3.3% | |
| Nov 17, 2017 | Crues John V | Medical Director | Sell | 40,000 | $9.90 | $395,990.00 | -3.2% | |
| Oct 3, 2017 | Kaminsky Sandy Nyholm | 10% Owner | Sell | 1,100,000 | $10.95 | $12,045,000.00 | -17.6% | |
| Sep 20, 2017 | Levitt Lawrence L58 | Director | Sell | 8,811 | $10.82 | $95,335.02 | -4.4% | |
| Sep 19, 2017 | Linden Jeffrey L | Executive Vice President | Sell | 18,192 | $10.95 | $199,202.40 | -1.9% | |
| Sep 19, 2017 | Levitt Lawrence L58 | Director | Sell | 6,189 | $11.04 | $68,326.56 | -3.0% | |
| Sep 12, 2017 | Sherman Michael L Md | Director | Sell | 11,965 | $11.02 | $131,854.30 | -4.0% |